Determining whether TSPO PET better delineates the true extent of tumor involvement as compared to MRI in patients with malignant glioma warrants further study, as it would have important clinical implications for detection, therapy planning, and post-treatment monitoring. The gene discussed is TSPO; the disease is malignant glioma.